MedTrace Logo

Urinary Bladder Matrix (UBM) Registry

NCT07805798 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2026-09-04

No results posted yet for this study

Summary

The purpose of this registry is to collect real-world information on patients treated with Urinary Bladder Matrix (UBM) products. The study will evaluate patient characteristics, treatment patterns, and clinical outcomes to better understand how UBM products are used in routine clinical practice and the outcomes experienced by patients over time.

Conditions

  • Tissue Repair
  • Soft Tissue Reconstruction
  • Wound Management
  • Pressure Ulcer (PU)
  • Necrotizing Soft Tissue Infection
  • Fournier's Gangrene
  • Pilonidal Cyst
  • Open Abdomen
  • Hidradenitis Suppurativa (HS)
  • Lower Extremity Wound
  • Incisional

Interventions

DEVICE

Urinary Bladder Matrix (UBM) Products

Commercially available UBM wound management products used as part of routine clinical practice. Treatment selection, application frequency, and wound management approach are determined by the treating clinician and are not dictated by the registry protocol.

Sponsors & Collaborators

  • Integra LifeSciences Corporation

    lead INDUSTRY

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-31
Primary Completion
2029-08-31
Completion
2029-12-31
FDA Device
Yes

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07805798 on ClinicalTrials.gov